|
|
|
Insider
Information: |
Schuler Jack W |
Relationship: |
|
City: |
Lake Forest |
State: |
IL |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
13 |
|
Direct
Shares |
27,956,178 |
|
Indirect Shares
|
61,134,751 |
|
|
Direct
Value |
$198,559,401 |
|
|
Indirect Value
|
$175,231,488 |
|
|
Total
Shares |
89,090,929 |
|
|
Total
Value |
$373,790,889 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
54
|
96
|
Stock
price went up :
|
14
|
2
|
Stock
price went down : |
40
|
94
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
-25.7%
|
-5,816.9%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Stericycle Inc |
SRCL |
Director |
2018-03-01 |
626,142 |
2018-03-01 |
56,460 |
Premium* |
|
Ventana Medical Systems Inc |
VMSI |
Director |
2008-02-08 |
0 |
2008-02-11 |
0 |
Premium* |
|
QuidelOrtho Corporation |
QDEL |
Director, 10% Owner |
2020-05-14 |
3,103,249 |
2018-01-22 |
3,414,053 |
Premium* |
|
Oncternal Therapeutics Inc |
ONCT |
10% Owner |
2014-03-21 |
6,165,261 |
2010-12-14 |
21,500 |
Premium* |
|
Transition Therapeutics |
TTHI |
10% Owner |
2011-11-22 |
2,823,010 |
2011-11-22 |
0 |
Premium* |
|
Yield10 Bioscience Inc |
YTEN |
|
2015-06-19 |
2,185,652 |
2023-12-20 |
63,789 |
Premium* |
|
Accelr8 Technology Corp |
AXDX |
Director, 10% Owner |
2024-05-29 |
15,488 |
2024-05-29 |
8,515,885 |
Premium* |
|
Aspira Womens Health Inc |
AWH |
|
2017-08-31 |
6,673,029 |
2023-07-24 |
1,883,656 |
Premium* |
|
Hansen Medical Inc |
HNSN |
Director |
2014-02-26 |
5,319,769 |
2014-02-26 |
13,249,640 |
Premium* |
|
Biolase Inc |
BIOL |
|
|
0 |
2020-02-11 |
759,820 |
Premium* |
|
Neos Therapeutics, Inc. |
NEOS |
10% Owner |
2015-07-28 |
1,044,578 |
2017-02-17 |
2,338,671 |
Premium* |
|
Soleno Therapeutics Inc |
SLNO |
|
2018-12-21 |
0 |
2022-12-09 |
36,595 |
Premium* |
|
Biodesix Inc |
BDSX |
|
2020-10-30 |
0 |
2024-05-23 |
30,794,682 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
634 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 20 of 26
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
SLNO |
Soleno Therapeutics Inc |
10% Owner |
|
2021-05-05 |
4 |
S |
$1.14 |
$283,149 |
I/I |
(248,115) |
9,749,043 |
0 |
% |
|
SLNO |
Soleno Therapeutics Inc |
10% Owner |
|
2021-05-18 |
4 |
S |
$1.03 |
$42,456 |
I/I |
(41,195) |
9,707,848 |
0 |
% |
|
SLNO |
Soleno Therapeutics Inc |
10% Owner |
|
2021-07-27 |
4 |
S |
$0.86 |
$17,074 |
I/I |
(19,748) |
4,065,044 |
0 |
% |
|
BDSX |
Biodesix Inc |
Director |
|
2021-08-13 |
4 |
B |
$7.50 |
$1,739,490 |
I/I |
232,000 |
5,956,513 |
2.25 |
- |
|
SLNO |
Soleno Therapeutics Inc |
10% Owner |
|
2021-08-17 |
4 |
S |
$0.78 |
$39,120 |
I/I |
(49,841) |
4,015,203 |
0 |
% |
|
BDSX |
Biodesix Inc |
Director |
|
2021-08-17 |
4 |
B |
$7.18 |
$211,447 |
I/I |
29,440 |
5,985,953 |
2.25 |
- |
|
BDSX |
Biodesix Inc |
Director |
|
2021-08-19 |
4 |
B |
$7.69 |
$384,440 |
I/I |
50,000 |
6,035,953 |
2.25 |
- |
|
SLNO |
Soleno Therapeutics Inc |
10% Owner |
|
2021-09-22 |
4 |
S |
$0.87 |
$2,270 |
I/I |
(2,599) |
4,012,604 |
0 |
% |
|
SLNO |
Soleno Therapeutics Inc |
10% Owner |
|
2021-09-23 |
4 |
S |
$0.88 |
$87,600 |
I/I |
(100,000) |
3,912,604 |
0 |
% |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2021-09-23 |
4 |
B |
$5.50 |
$150,442 |
I/I |
27,353 |
16,660,454 |
2.25 |
% |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2021-09-24 |
4 |
B |
$5.45 |
$1,047,490 |
I/I |
192,200 |
16,852,654 |
2.25 |
% |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2021-09-27 |
4 |
B |
$5.33 |
$799,500 |
I/I |
150,000 |
17,002,654 |
2.25 |
% |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2021-09-28 |
4 |
B |
$5.31 |
$318,483 |
I/I |
59,978 |
17,062,632 |
2.25 |
% |
|
BDSX |
Biodesix Inc |
Director |
|
2021-11-17 |
4 |
B |
$6.51 |
$130,104 |
I/I |
20,000 |
6,055,953 |
2.25 |
- |
|
BDSX |
Biodesix Inc |
Director |
|
2021-11-18 |
4 |
B |
$6.33 |
$179,502 |
I/I |
28,361 |
6,084,314 |
2.25 |
- |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2021-11-22 |
4 |
B |
$5.06 |
$247,874 |
I/I |
48,987 |
17,284,913 |
2.25 |
% |
|
BDSX |
Biodesix Inc |
Director |
|
2021-11-22 |
4 |
B |
$6.34 |
$126,756 |
I/I |
20,000 |
6,164,314 |
2.25 |
- |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2021-11-29 |
4 |
B |
$5.00 |
$5,000,000 |
I/I |
1,000,000 |
18,284,913 |
2.25 |
% |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2021-12-15 |
4 |
B |
$4.38 |
$74,679 |
I/I |
17,050 |
18,301,963 |
2.25 |
% |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2021-12-16 |
4 |
B |
$4.60 |
$92,000 |
I/I |
20,000 |
18,321,963 |
2.25 |
% |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2021-12-17 |
4 |
B |
$4.98 |
$369,152 |
I/I |
74,127 |
18,396,090 |
2.25 |
% |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2021-12-20 |
4 |
B |
$4.73 |
$257,979 |
I/I |
54,541 |
18,450,631 |
2.25 |
% |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2021-12-28 |
4 |
B |
$4.87 |
$146,100 |
I/I |
30,000 |
18,480,631 |
2.25 |
% |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2021-12-29 |
4 |
B |
$4.83 |
$130,709 |
I/I |
27,062 |
18,507,693 |
2.25 |
% |
|
BDSX |
Biodesix Inc |
Director |
|
2021-12-30 |
4 |
B |
$4.35 |
$9,999,998 |
I/I |
2,298,850 |
8,463,164 |
2.25 |
- |
|
634 Records found
|
|
Page 20 of 26 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|